Silvergate News

EPANED® (enalapril maleate) Oral Solution 1 mg/mL, the First and Only FDA-Approved Enalapril Oral Solution for the Treatment of Pediatric Hypertension in Patients Older than 1 Month, is Now Available

Denver, July 31, 2017 — Silvergate Pharmaceuticals, Inc. (www.silvergatepharma.com), leaders in the development and commercialization of innovative and safe medicines for children, today announced that Xatmep™ (methotrexate) Oral Solution, the first and only...

read more